Cytosorbents Corporation (CTSO)

1.00

0.00 (0.00%)

At close: Apr 01, 2025, 3:59 PM

1.00

0.00%

After-hours: Apr 01, 2025, 04:40 PM EDT

Cytosorbents Cash Flow Statement

Chart Mode

Year	FY24	FY23	FY22	FY21	FY20
Net Income	-20.72M	-28.51M	-32.81M	-24.56M	-7.84M
Depreciation & Amortization	438.73K	2.03M	1.13M	1.13M	660.79K
Stock-Based Compensation	3.76M	3.7M	3.8M	6.2M	4.71M
Other Working Capital	n/a	1.1M	3,249B	145.06K	-1,424.4B
Other Non-Cash Items	2.09M	-1.24M	3.21M	2.58M	322.81K
Deferred Income Tax	n/a	n/a	n/a	n/a	-2.71M
Change in Working Capital	n/a	2.36M	-3.56M	641.9K	-757.87K
Operating Cash Flow	-14.43M	-21.66M	-28.23M	-14.01M	-5.61M
Capital Expenditures	-284.34K	-936.24K	-6.46M	-4.28M	-1.68M
Acquisitions	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	-385.09K	-398.12K	-368.21K	-640.01K	-967.82K
Investing Cash Flow	-669.43K	-936.24K	-6.46M	-4.28M	-1.68M
Debt Repayment	n/a	n/a	5M	n/a	-15M
Common Stock Repurchased	n/a	n/a	-40.36K	-90K	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	9.33M	218.28K	-40.36K	715.2K	1.13M
Financial Cash Flow	9.33M	14.47M	4.96M	715.2K	66.35M
Net Cash Flow	-5.85M	-8.22M	-29.99M	-17.6M	59.19M
Free Cash Flow	-14.71M	-22.59M	-34.69M	-18.29M	-7.29M